(Circulation. 2000;102:572.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
Fas-Mediated Apoptosis in Adriamycin-Induced Cardiomyopathy in Rats
In Vivo Study
From the Departments of Pediatrics (T.N., H.T., E.K.) and Pathology (Y.U., Y.J., S.K.), Kanazawa Medical University, Ishikawa, Japan.
Correspondence to Eikan Koh, Department of Pediatrics, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Ishikawa 920-0293, Japan. E-mail p-koh{at}kanazawa-med.ac.jp
Background—The precise molecular mechanism of Adriamycin-induced cardiomyopathy (ADR-CM) is still unknown. We address the demonstration of apoptotic myocardial cell death and the apoptosis-inducing molecules in ADR-CM induced in rats.
Methods and Results—Until 8 weeks after the first administration of ADR, there was no increase in the number of labeled cells by terminal deoxynucleotidyl transferase assay (TUNEL method). Apoptotic indices increased significantly at weeks 9 and 10 in hearts of the ADR-treated group but not in those of the control group (0.42±0.12% versus 0.10±0.02% and 0.86±0.11% versus 0.09±0.04% at weeks 9 and 10, respectively). DNA ladder formation was also observed in the myocardial tissues during the late stages of the ADR-CM of rats. There was no significant difference in expression of p53 gene between the ADR group and the control group at either the message or the protein level. An overexpression of Fas antigen was shown in myocardial cells of ADR-treated hearts at weeks 9 and 10 by both Western blotting and immunofluorescent staining. Furthermore, we confirmed that neutralization of anti–Fas ligand antibody inhibited ADR-induced apoptosis.
Conclusions—Apoptotic cell death was observed in the hearts of ADR-CM rats, and the number of apoptotic myocardial cells increased with the deterioration of morphological findings and cardiac function, indicating that apoptosis may be an important mechanism of loss of myocardial cells and cardiac dysfunction in ADR-CM. Apoptosis in ADR-CM rats is not p53-dependent but rather is executed through a Fas-mediated pathway.
Key Words: apoptosis • cardiomyopathy • doxorubicin hydrochloride
This article has been cited by other articles:
 |
|
 |
|
  J. Niu, A. Azfer, K. Wang, X. Wang, and P. E. Kolattukudy Cardiac-Targeted Expression of Soluble Fas Attenuates Doxorubicin-Induced Cardiotoxicity in Mice J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Chua, J. Gao, Y.-S. Ho, X. Xu, I-C. Kuo, K.-Y. Chua, H. Wang, R. C. Hamdy, J. C. Reed, and B. H.L. Chua Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice Cardiovasc Res, January 1, 2009; 81(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Deng, B. Kulle, M. Hosseini, G. Schluter, G. Hasenfuss, L. Wojnowski, and A. Schmidt Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity Eur J Heart Fail, October 1, 2007; 9(10): 986 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Neilan, G. A. Doherty, G. Chen, C. Deflandre, H. McAllister, R. K. Butler, S. E. McClelland, E. Kay, L. R. Ballou, and D. J. Fitzgerald Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H532 - H536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Li, R. Y. T. Sung, W. Z. Huang, M. Yang, N. H. Pong, S. M. Lee, W. Y. Chan, H. Zhao, M. Y. To, T. F. Fok, et al. Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin Circulation, May 9, 2006; 113(18): 2211 - 2220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Neilan, D. S. Jassal, M. F. Scully, G. Chen, C. Deflandre, H. McAllister, E. Kay, S. C. Austin, E. F. Halpern, J. H. Harmey, et al. Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression Eur. Heart J., May 2, 2006; 27(10): 1251 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yi, R. Bekeredjian, N. J. DeFilippis, Z. Siddiquee, E. Fernandez, and R. V. Shohet Transcriptional analysis of doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1098 - H1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thorburn and A. E. Frankel Apoptosis and anthracycline cardiotoxicity. Mol. Cancer Ther., February 1, 2006; 5(2): 197 - 199. [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lien, S.-M. Lin, R. Nithipongvanitch, T. D. Oberley, T. Noel, Q. Zhao, C. Daosukho, and D. K. St. Clair Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection. Mol. Cancer Ther., February 1, 2006; 5(2): 261 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Lipshultz, S. R. Lipsitz, S. E. Sallan, V. M. Dalton, S. M. Mone, R. D. Gelber, and S. D. Colan Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia J. Clin. Oncol., April 20, 2005; 23(12): 2629 - 2636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, E. A. Konorev, S. Kotamraju, J. Joseph, S. Kalivendi, and B. Kalyanaraman Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms: INTERMEDIACY OF H2O2- AND p53-DEPENDENT PATHWAYS J. Biol. Chem., June 11, 2004; 279(24): 25535 - 25543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L'Ecuyer, Z. Allebban, R. Thomas, and R. Vander Heide Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2057 - H2064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. FOGLI, P. NIERI, and M. C. BRESCHI The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage FASEB J, April 1, 2004; 18(6): 664 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Liu, C. C. Chua, J. Gao, Z. Chen, C. L. C. Landy, R. Hamdy, and B. H. L. Chua Pifithrin-{alpha} protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H933 - H939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q Z Feng, T D Li, L X Wei, X Qiao, J Yi, L Wang, and T S Yang Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion Mol. Pathol., December 1, 2003; 56(6): 362 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res, September 1, 2003; 59(3): 549 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Qin, J. Shite, and C.-s. Liang Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamanaka, T. Tatsumi, J. Shiraishi, A. Mano, N. Keira, S. Matoba, J. Asayama, S. Fushiki, H. Fliss, and M. Nakagawa Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes J. Am. Coll. Cardiol., March 5, 2003; 41(5): 870 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lee, M. Sata, D. J. Lefer, S. M. Factor, K. Walsh, and R. N. Kitsis Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H456 - H463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nitobe, S. Yamaguchi, M. Okuyama, N. Nozaki, M. Sata, T. Miyamoto, Y. Takeishi, I. Kubota, and H. Tomoike Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes Cardiovasc Res, January 1, 2003; 57(1): 119 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Baldanzi, N. Filigheddu, S. Cutrupi, F. Catapano, S. Bonissoni, A. Fubini, D. Malan, G. Baj, R. Granata, F. Broglio, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT J. Cell Biol., December 23, 2002; 159(6): 1029 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Roger Brown, Hong Ni, G. Benavides, L. Yoon, K. Hyder, J. Giridhar, G. Gardner, R. D. Tyler, and K. T. Morgan Correlation of Simultaneous Differential Gene Expression in the Blood and Heart with Known Mechanisms of Adriamycin-Induced Cardiomyopathy in the Rat Toxicol Pathol, June 1, 2002; 30(4): 452 - 469. [Abstract] [PDF]
|
|
|
|
|
|
E. Lorenzo, C. Ruiz-Ruiz, A. J. Quesada, G. Hernandez, A. Rodriguez, A. Lopez-Rivas, and J. M. Redondo Doxorubicin Induces Apoptosis and CD95 Gene Expression in Human Primary Endothelial Cells through a p53-dependent Mechanism J. Biol. Chem., March 22, 2002; 277(13): 10883 - 10892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kunisada, E. Tone, S. Negoro, Y. Nakaoka, Y. Oshima, T. Osugi, M. Funamoto, M. Izumi, Y. Fujio, H. Hirota, et al. Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation Cardiovasc Res, March 1, 2002; 53(4): 936 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. GILL, R. MESTRIL, and A. SAMALI Losing heart: the role of apoptosis in heart disease--a novel therapeutic target? FASEB J, February 1, 2002; 16(2): 135 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Kalivendi, S. Kotamraju, H. Zhao, J. Joseph, and B. Kalyanaraman Doxorubicin-induced Apoptosis Is Associated with Increased Transcription of Endothelial Nitric-oxide Synthase. EFFECT OF ANTIAPOPTOTIC ANTIOXIDANTS AND CALCIUM J. Biol. Chem., December 7, 2001; 276(50): 47266 - 47276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Qin, N. K. Rounds, W. Mao, K. Kawai, and C.-s. Liang Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets Cardiovasc Res, September 1, 2001; 51(4): 736 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Maruyama, G. Takemura, T. Aoyama, K. Hayakawa, M. Koda, Y. Kawase, X. Qiu, Y. Ohno, S. Minatoguchi, K. Miyata, et al. Dynamic Process of Apoptosis in Adult Rat Cardiomyocytes Analyzed Using 48-Hour Videomicroscopy and Electron Microscopy : Beating and Rate are Associated with the Apoptotic Process Am. J. Pathol., August 1, 2001; 159(2): 683 - 691. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Zhou, X. Sun, and Y. J. Kang Ethanol-Induced Apoptosis in Mouse Liver : Fas- and Cytochrome c-Mediated Caspase-3 Activation Pathway Am. J. Pathol., July 1, 2001; 159(1): 329 - 338. [Abstract] [Full Text] [PDF]
|
|